Holding/activity history for Inhibrx (INBX)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price |
| 2024 Q3 | 1,787,705 | 0.10 | $15.66 | ||
| 2024 Q2 | 1,787,705 | 0.10 | Reduce 75.00% | 0.30 | $14.17 |
| 2024 Q1 | 7,150,826 | 0.93 | $34.96 | ||
| 2023 Q4 | 7,150,826 | 1.00 | $38.00 | ||
| 2023 Q3 | 7,150,826 | 0.53 | Add 7.71% | 0.04 | $18.35 |
| 2023 Q2 | 6,639,199 | 0.71 | $25.96 | ||
| 2023 Q1 | 6,639,199 | 0.59 | $18.87 | ||
| 2022 Q4 | 6,639,199 | 0.82 | Add 25.13% | 0.16 | $24.64 |
| 2022 Q3 | 5,305,866 | 0.44 | $17.95 | ||
| 2022 Q2 | 5,305,866 | 0.28 | $11.35 | ||
| 2022 Q1 | 5,305,866 | 0.48 | $22.28 | ||
| 2021 Q4 | 5,305,866 | 0.67 | $43.67 | ||
| 2021 Q3 | 5,305,866 | 0.49 | $33.31 | ||
| 2021 Q2 | 5,305,866 | 0.44 | $27.52 | ||
| 2021 Q1 | 5,305,866 | 0.32 | $20.07 | ||
| 2020 Q4 | 5,305,866 | 0.48 | $32.97 | ||
| 2020 Q3 | 5,305,866 | 0.35 | Buy | 0.35 | $18.00 |